Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Legal
  • M&A
  • News

Acquisition Of Abcam By Danaher For $24.00 Per Share In Cash Approved By The High Court Of Justice Of England And Wales

By Benzinga Newsdesk
December 4, 5:02 PM
Abcam plc (NASDAQ:ABCM) (‘Abcam', the ‘Group' or the ‘Company'), a global leader in the supply of life science research tools, entered into a definitive agreement on August 26, 2023 relating to its proposed acquisition

ABCM

Read More
2 minute read
  • M&A
  • News

Jonathan Milner Welcomes Glass Lewis Report Insights, Urges Shareholders To Reject Abcam’s Sale To Danaher

By Benzinga Newsdesk
October 23, 2:57 AM
Commenting on the report, Jonathan Milner issued the following statement: "I welcome Glass Lewis's scrutiny of the pressing issues surrounding excessive executive pay and bonuses, aspects also recently covered

ABCM

Read More
2 minute read
  • M&A
  • Management
  • News

Jonathan Milner Releases Presentation To Abcam Shareholders, Outlining Reasons To Reject Danaher’s Bid And Strategic Vision For The Company

By Benzinga Newsdesk
October 16, 10:34 AM
Jonathan Milner releases presentation to Abcam plc shareholders, outlining reasons to reject Danaher's bid and strategic vision for the CompanyCAMBRIDGE, England, 16 October 2023 – Dr. Jonathan Milner, the founder and

ABCM

Read More
5 minute read
  • M&A

Abcam Files And Mails Scheme Circular Seeking Approval Of Acquisition Of Abcam By Danaher For $24.00 Per Share

By Benzinga Newsdesk
October 5, 8:12 AM
Abcam plc (NASDAQ:ABCM) (‘Abcam', the ‘Group' or the ‘Company'), a global leader in the supply of life science research tools, today filed and mailed a scheme circular (the 'Scheme Circular‘) in connection with the

ABCM

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Equities
  • General
  • Markets
  • News
  • Price Target
  • Reiteration
  • Trading Ideas

Danaher Bears The Brunt Of Macro Woes: Analyst Flags Lower Demand, Reduced Funding & Weakness In China

By Nabaparna Bhattacharya
September 27, 3:37 PM
KeyBanc Capital Markets analyst Paul Knight reiterated the Overweight rating on Danaher Corporation (NYSE: DHR), 

ABCM

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • General
  • Health Care
  • M&A
  • News
  • Trading Ideas

Danaher’s Strategic Abcam Deal Boosts Growth at a Reasonable Price: Analyst

By Vandana Singh
August 29, 3:09 PM
Monday, Danaher Corporation (NYSE: DHR) had agreed to acquire Abcam plc (NASDAQ: ABCM) for $24.00 per share in cash, or a total enterprise value of ~$5.7 billion, including assumed indebtedness 

ABCM

Read More
2 minute read
  • Biotech
  • Earnings
  • General
  • Guidance
  • Health Care
  • Hedge Funds
  • Management
  • Movers
  • News
  • Trading Ideas

Beaten Down COVID-19 Vaccine Partner Stock Catalent Finalizes Deal With Activist Investor, Reports Mixed Q4 Earnings

By Vandana Singh
August 29, 8:17 AM
Catalent Inc (NYSE: CTLT), valued at around $8 billion, has finalized a deal with activist investor Elliott Investment Management. 

ABCM

Read More
1 minute read
  • General
  • M&A
  • News
  • Trading Ideas

Health Care Company Danaher Announces Acquisition of Abcam

By Benzinga Insights
August 28, 11:10 AM
Danaher (NYSE:DHR) has announced an acquisition of Abcam (NASDAQ:ABCM) that is expected to be completed 2024-H1. Under the…

ABCM

Read More
1 minute read
  • Equities
  • M&A
  • Markets
  • Movers
  • News

Danaher Acquires Abcam In $5.7B Deal; ABCM Is Sliding Below Deal Price – Here’s Why

By Akanksha Bakshi
August 28, 9:18 AM
Danaher Corporation (NYSE: DHR) has 

ABCM

Read More
1 minute read
  • Analyst Ratings

Expert Ratings for Abcam

By Benzinga Insights
August 22, 2:00 PM
Abcam (NASDAQ:ABCM) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

ABCM

Posts pagination

1 2 3 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service